Effect of Science Research Wellness Ndo1 on Glycaemia in Adults With Pre-diabetes

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

July 1, 2025

Study Completion Date

July 8, 2025

Conditions
Prediabetes
Interventions
DIETARY_SUPPLEMENT

SRW Ndo1

The investigational product (IP) is a health supplement for glycaemic control. Each capsule contains 80 mg of dahlia4® (Dahlia pinnata extract), 80 mg of Eriomin® (Citrus limon extract), and 100 mg of Mulberry leaf extract (with 5% 1-deoxynojirimycin).

Trial Locations (1)

Unknown

Baohua, Guangzhou

All Listed Sponsors
lead

Wellizen Australia

INDUSTRY